TurnbaughPJLeyREHamadyMet al. The human microbiome project. Nature2007; 449(7164): 804–810.
2.
LeeYKMenezesJSUmesakiYet al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA2011; 108(Suppl. 1): 4615–4622.
3.
BererKMuesMKoutrolosMet al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature2011; 479(7374): 538–541.
4.
Ochoa-ReparazJMielcarzDWDitrioLEet al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol2009; 183(10): 6041–6050.
5.
Ochoa-ReparazJMielcarzDWWangYet al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol2010; 3(5): 487–495.
6.
HaghikiaAJorgSDuschaAet al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity2015; 43(4): 817–829.
7.
RothhammerV.Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med2016; 22(6): 586–597.
8.
JangiSGandhiRCoxLMet al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun2016; 7: 12015.
9.
TremlettHH. Gut microbiota in early pediatric multiple sclerosis: A case-control study. Eur J Neurol23(8): 1308–1321.
10.
CasacciaPZhuYCekanaviciuteEet al. Effect of oral versus injectable disease-modifying therapies on the epigenome-wide DNA methylation and gut microbiota in multiple sclerosis patients. Mult Scler J2016; 22: 598.
11.
ForslundK. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature528: 262–266.
12.
TremlettHFadroshDWFaruqiAAet al. Gut microbiota composition and relapse risk in pediatric MS: A pilot study. J Neurol Sci363: 153–157.
